1
Deiman, Birgit, Tonino, W.A.L., Kouhestani, K., Schrover, C.E., Scharnhorst, V., Dekker, L.R.C., Pijls, N.H.J.
Veröffentlicht in: Deiman , B , Tonino , W A L , Kouhestani , K , Schrover , C E , Scharnhorst , V , Dekker , L R C & Pijls , N H J 2016 , ' Reduced number of cardiovascular events and increased cost-effectiveness by genotype-guided antiplatelet therapy in patients undergoing percutaneous coronary interventions in the Netherlands ' , Netherlands Heart Journal , vol. 24 , no. 10 , pp. 589–599 . https://doi.org/10.1007/s12471-016-0873-z;
2016
Veröffentlicht in: Deiman , B , Tonino , W A L , Kouhestani , K , Schrover , C E , Scharnhorst , V , Dekker , L R C & Pijls , N H J 2016 , ' Reduced number of cardiovascular events and increased cost-effectiveness by genotype-guided antiplatelet therapy in patients undergoing percutaneous coronary interventions in the Netherlands ' , Netherlands Heart Journal , vol. 24 , no. 10 , pp. 589–599 . https://doi.org/10.1007/s12471-016-0873-z;
2016